Form 4: Precigen Executive Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Precigen's Chief Commercial Officer, Phil Tennant, sold 30,272 shares of common stock to cover tax obligations upon the vesting of restricted stock units.
Summary
- Phil Tennant, Chief Commercial Officer of Precigen, Inc., reported a transaction involving the sale of 30,272 shares of common stock.
- The sale occurred on May 28, 2026, and was a 'sell-to-cover' transaction to satisfy tax withholding obligations.
- These obligations arose from the vesting of restricted stock units on May 23, 2026.
- The shares were sold at a price of $4.36 per share.
- Following this transaction, Mr. Tennant beneficially owns 139,369 shares of Precigen common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard, non-discretionary transaction to cover tax obligations rather than a strategic decision to buy or sell shares based on market outlook.
Positives
- The transaction was a 'sell-to-cover' to meet tax obligations, indicating a standard procedure for executive compensation events.
- The executive continues to hold a significant number of shares (139,369) after the transaction.
Negatives
- A portion of the executive's equity compensation was sold, reducing their direct holdings.
Future Outlook
No specific future outlook or guidance is provided in this Form 4 filing, which details a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are routine disclosures for publicly traded companies, detailing changes in beneficial ownership by insiders. This specific filing indicates a standard practice for executives to cover tax liabilities associated with equity awards.
Stakeholder Impact
- Shareholders: The sale is a routine tax event for an executive and does not inherently signal a change in the executive's long-term conviction in the company's stock, as the shares were sold to cover obligations.
- Employees: This filing is specific to executive compensation and does not directly impact other employees.
- Management: Highlights a standard process for managing executive compensation and tax liabilities.
Key Dates
| Date | Description |
|---|---|
| 05/23/2026 | Vesting of restricted stock units. |
| 05/28/2026 | Transaction date for the sale of common stock. |
| 06/01/2026 | Date of signature for the filing. |
Keywords
Precigen, PGEN, Form 4, Insider Trading, Stock Sale, Executive Compensation, Restricted Stock Units, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.